All News

The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.

Why text messaging is good for the business of health care

In using the biomarker approach to the treatment of triple-negative breast cancer, the challenge for the clinician is prioritizing the available treatment options based on the National Comprehensive Cancer Network guidelines for breast cancer, which focus on active agents, preferred single-agent chemotherapy approaches, and doublet options for certain patients at high risk.

Here's what's coming up this week on Contemporary OB/GYN®

Blood clot risk in J&J higher for women, draws CDC concerns

Take a look back at the top 10 women’s health news articles published on Drug Topics® this year.

The vaccine, which protects patients from seven different strains related to HPV-related cancers, may be considered part of routine oncology care for survivors.

Here's what you missed this week from Contemporary OB/GYN.

Many of the glaring disparities that exist in care for the 26 million women in the United States who suffer from uterine fibroids, which disproportionately affects up to 80% of Black women, are being aggressively addressed though a new multifaceted campaign called UNmuting Fibroids.

A study in JAMA Cardiology found that women who delivered preterm had greater than a 50% increased risk of hypertension within the next 10 years, and that risk more than doubled in cases of extreme preterm, compared to women who delivered full term.

Research shows that telemedicine bridges gaps in healthcare access despite party affiliations.

Treatment programs that often use neoadjuvant chemotherapy as a strategy may help prolong survival in patients with advanced ovarian cancer compared with those that infrequently used the tactic, which may reassure patients and providers.

A population-based retrospective cohort study in JAMA Network Open concluded that maternal sexually transmitted infections (STIs) are significantly linked to an increased risk of preterm birth in the United States.

In this episode of Pap Talk, Gloria A. Bachmann, MD, MMS sat down with Michael Krychman, MD, at the North American Menopause Society (NAMS) Annual Meeting to talk about telemedicine and her work providing trauma-informed care to women in prison.

A new national survey reveals the pressing need for better maternal mental health planning.

The pandemic’s impact could worsen gender divide in income and career prospects, study finds.

A study in JAMA Network Open has concluded that women who undergo bilateral oophorectomy before menopause are significantly more likely to develop mild cognitive impairment and poorer performance on cognitive tests about 30 years later compared to women who do not have the procedure.

A new study found that reproductive history indicators were not directly linked to cognitive measures of Alzheimer’s disease (AD) in midlife women.

Physical and sexual violence while on a date can have long-term traumatic effects for teens and adolescents. A metanalysis examines whether prevention programs are effective at reducing the incidence of violence.

Check out the latest updates and coverage from the American Association of Gynecologic Laparoscopists’ 50th Global Congress on minimally invasive gynecologic surgery.

Black patients may have poorer outcomes during breast cancer treatment than white patients.

A look at what's coming to Contemporary OB/GYN® this week

The addition of palbociclib to endocrine therapy was not associated with preventing disease recurrence in patients with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative early breast cancer, according to final results of the phase 3 PALLAS trial.

The study results — which were presented during the 2021 San Antonio Breast Cancer Symposium — indicated that elacestrant, a selective estrogen receptor degrader (SERD), led to a 30% reduction in the risk of disease progression or death compared with standard of care in the study population.

What you missed this week on Contemporary OB/GYN®

Vice President Kamala Harris hosted the White House’s first-ever Maternal Health Day of Action Summit on Dec. 7. During the Summit, Harris outlined the administration’s new initiatives and issued a nationwide call to action for public and private sectors to help improve maternal health outcomes.

A recent analysis suggests transfeminine individuals were at a 40% greater risk of developing diabetes than their cisgender counterparts, but this increase in risk was not attributable to gender-affirming hormone therapy.

Patients in California were able to receive a contraceptive prescription during a visit with a pharmacist.